Ann: New Drug Application for AXIRON accepted for, page-10

re: Ann: New Drug Application for AXIRON acce... emmjay - i also got in with half my holding at 50c but I see that as a total anomaly and one that is symptomatic of the problem. $1.50-$2 was a fair price for the company before the news based on the speculative nature and the what, $1 float price?

Now we have blue skies for ACR and a clear path forward for actual cash in the bank, almost a no brainer with most analysts putting approval at 90-95%. If the next $150m comes rolling in the P/B ration will be 1:1, since they have about $80m in assets today.